Inventor

SUDHAKAR ANANTHA

US41 patents

⚠️ This page may combine multiple inventors who share the name “SUDHAKAR ANANTHA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SUDHAKAR ANANTHA

SCHERING CORP

Process for the stereospecific synthesis of azetidinones

Process for the stereospecific synthesis of azetidinones

Crystalline antifungal polymorph

Process for the preparation of triazolones

Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof

Process and intermediates for the preparation of (1R,2S,5S)-3-azabicyclo[3,1,0]hexane-2-carboxamide, N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[1,1-dimethylethyl]amino]carbonylamino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl

Chiral hydrazine derivatives

Synthesis of 2-hydroxy-N,N-dimethyl-3-[ [2-[1 (R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]aminobenzamide

Process for preparing intermediates for the synthesis of antifungal agents

Synthesis of 2-Hydroxy-N,N-dimethyl-3-[[2-[[1(R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide

Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[[1(r)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide

Process for preparing intermediates for the synthesis of antifungal agents

Exo- and diastereo-selective syntheses of himbacine analogs

Synthesis of quinoline 5-carboxamides useful for the preparation of PDE IV inhibitors

DENALI THERAPEUTICS INC

Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

Process for the preparation of pyrimidinyl-4-aminopyrazole compounds

Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide

Process for the preparation of pyrimidinyl-4-aminopyrazole compounds

Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

Compounds, compositions and methods

Compounds, compositions and methods

Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1)

SUNESIS PHARMACEUTICALS INC

Stable SNS-595 compositions and methods of preparation

Stable SNS-595 compositions and methods of preparation

Compounds and compositions for treatment of cancer

Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid

Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid

SUDHAKAR ANANTHA

Stable SNS-595 compositions and methods of preparation

Compounds and methods for treatment of cancer

Stable SNS-595 compositions and methods of preparation

Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid

ADELMAN DANIEL C

1,8-naphthyridine compounds for the treatment of cancer

1,8-naphthyridine compounds for the treatment of cancer

WU GEORGE G

Exo- and diastereo-selective synthesis of himbacine analogs

Exo- and diastereo- selective synthesis of himbacine analogs

THIRUVENGADAM TIRUVETTIPURAM K

Exo-selective synthesis of himbacine analogs

Exo-selective synthesis of himbacine analogs

(unassigned)

Crystalline antifungal polymorph

UNIV COLUMBIA

Helical metallocene oligomers and a method for their preparation

SCHERING PLOUGH CORP

Chiral hydrazine derivatives